Wanted: manufacturer for Ebola and Marburg vaccines

Lett, Dan
August 2005
CMAJ: Canadian Medical Association Journal;8/30/2005, Vol. 173 Issue 5, p472
Academic Journal
Reports on the search for private-sector contractor to conduct human trials and manufacture the vaccines for Ebola and Marburg hemorrhagic fever in 2005, according to Steven Jones, a research scientist at the Winnipeg, Manitoba-based National Microbiology Laboratories and codiscoverer of the vaccines. Type of strains which served as the basis for the Marburg vaccine; Symptoms of Ebola or Marburg fever; Number of people who were killed by an outbreak of Marburg as of July 29, 2005 according to the World Health Organization.


Related Articles

  • Ebola unleashed. MANOCHA, VANI // Down to Earth;9/1/2014, Vol. 23 Issue 8, p14 

    The article discusses the nature, causes, and symptoms of the Ebola virus outbreak in West Africa. Brief overview of the history of the emergence of the outbreak, how it can be transmitted to family members or healthcare staff, and the effort of the Indian government to prevent the country from...

  • Ebola vaccine: It's not so simple. hiltzik, michael // Investigate;Feb/Mar2015, Issue 148, p42 

    Information about the emergency conference convened by the World Health Organization at the end of September 2014 is presented. The conference puts emphasis on the possible vaccines to treat the Ebola virus disease. Among the topics discussed include the test of Ebola virus vaccines, human...

  • As Ebola Epidemic Begins to Slow, Trials of Drugs and Vaccines Speed Up. Kuehn, Bridget M. // JAMA: Journal of the American Medical Association;3/10/2015, Vol. 313 Issue 10, p1000 

    The article reports on the rapid development of therapies and vaccines against Ebola virus disease and the slowing down of the Ebola epidemic in West Africa. Topics discussed include the decline of Ebola cases in Western Africa, according to the World Health Organization (WHO), the international...

  • Ebola.  // WHO Drug Information;2014, Vol. 28 Issue 4, p459 

    The article offers updates on the treatments for virus disease Ebola. Topics discussed include the convalescent blood and plasma therapies approach including its feasibility of implementation, rolling review procedure advise by European Medicines Agency (EMA) for the development plan of Ebola...

  • Ebola vaccine efficacy trial ready to launch in Guinea.  // African Business News;3/5/2015, p1 

    No abstract available.

  • Ebola haemorrhagic fever, Uganda -- end of the outbreak.  // Weekly Epidemiological Record;3/7/2008, Vol. 83 Issue 10, p89 

    The article offers information on the declaration by the Ministry of Health of Uganda that the Ebola hemorrhagic fever outbreak in Bundibugyo, Uganda, was over. The declaration was made on February 20, 2008, and the last person to be infected by the virus was discharged on January 8, 2008. The...

  • Ethics in a Time of Ebola. Cook, Michael // Australasian Science;Oct2014, Vol. 35 Issue 8, p50 

    The article discusses ethical issues that need to be considered with regard to the Ebola virus epidemic in West Africa. Topics explored include the statement issued by the World Health Organization (WHO) about the administration of untested drugs to Ebola patients, the need to prioritise safety...

  • Ebola Diagnosed In Mali, NYC. Investor's Business Daily // Investors Business Daily;10/27/2014, pB02 

    6 The WHO declared Nigeria as Ebola-free. But the disease spread to a toddler in Mali. A Spanish nurse, 2 Dallas nurses and an NBC cameraman are all rid of it, but an NYC doctor who returned from Guinea tested positive Thu. and was hospitalized. Johnson &

  • Statistics and logistics: Design of Ebola vaccine trials in West Africa. Nason, Martha // Clinical Trials;Feb2016, Vol. 13 Issue 1, p87 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics